Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions (original) (raw)
Progress of Hematopoietic Stem Cell Transplantation and Radiotherapy in the Treatment of Extranodal NK/T Cell Lymphoma
Layal Sharrouf
Frontiers in Oncology, 2022
View PDFchevron_right
Efficacy of L-Asparaginase Combination Therapy in Localized Extranodal NK/T-Cell Lymphoma: A Single Institution Experience
Abdessamed Arabi
Journal of Hematology and Thromboembolic Diseases, 2013
View PDFchevron_right
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan
Jun Itami
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017
View PDFchevron_right
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
Monica Civallero
The Lancet Haematology, 2020
View PDFchevron_right
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
Ruey-Long Hong
Journal of radiation research, 2016
View PDFchevron_right
First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
Liang Wang
Cancer, 2013
View PDFchevron_right
Extranodal NK/T-cell lymphoma, nasal type : New staging system and treatment strategies
kim min
Cancer Science, 2009
View PDFchevron_right
A five-year retrospective study of treatment outcomes using the L-asparaginase-based regimen as a first-line chemotherapy protocol for patients diagnosed with extranodal NK/T-cell lymphoma, nasal-type, in Thailand
Archrob Khuhapinant
Hematology
View PDFchevron_right
Extranodal NK/T-cell lymphoma: diagnosis and treatment cues
Kengo Takeuchi
Hematological Oncology, 2008
View PDFchevron_right
Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience
Roberta Demichelis-gómez
Blood Research, 2018
View PDFchevron_right
Case report Nasal type extranodal natural killer T-cell lymphoma in a laryngeal cancer survivor: the first case report
Arzu Tasdemir
2014
View PDFchevron_right
Progress in the treatment of NK-cell lymphoma/leukemia
Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment, 2021
View PDFchevron_right
Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy
Ivan Tham
Head & Neck, 2006
View PDFchevron_right
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Olivier Hermine
Blood, 2010
View PDFchevron_right
Defining the toxicity of current regimens for extranodal NK/T cell lymphoma: a systematic review and metaproportion
Вадим Покровский
Expert Review of Anticancer Therapy, 2018
View PDFchevron_right
Extranodal NK/T cell lymphoma- nasal type: Experience from an Indian regional cancer centre
Govind Babu K
Annals of Oncology, 2018
View PDFchevron_right
Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
Eric Tse
Advances in Hematology, 2010
View PDFchevron_right
NHL - Extranodal T-cell lymphoma
Seema Devi
National Journal of Maxillofacial Surgery, 2015
View PDFchevron_right
Extranodal Natural Killer/T-Cell Lymphoma: A Rare Nasal-Type Case
Unsal Han
Turkish journal of hematology, 2016
View PDFchevron_right
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
John Greer
Journal of the National Comprehensive Cancer Network : JNCCN, 2018
View PDFchevron_right
Extranodal NK/T-cell lymphoma, nasal type (ENKL)
LUIS MIGUEL JUAREZ SALCEDO
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2019
View PDFchevron_right
An unusual case of lymphoma — a case of extranodal NK/T-cell lymphoma, nasal type
Lindokuhle Goqwana
The Egyptian Journal of Otolaryngology
View PDFchevron_right
Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors
Pin-pen Hsieh
Human pathology, 2015
View PDFchevron_right
Extranodal NK/T-cell Lymphoma, Nasal Type, Includes Cases of Natural Killer Cell and αβ, γδ, and αβ/γδ T-cell Origin
Paisarn Boonsakan, Pongsak Wannakrairot
The American Journal of Surgical Pathology, 2012
View PDFchevron_right
Extranodal NK/T-cell Lymphoma, Nasal Type: Study of Clinicopathologic and Prognosis Factors in a Series of 78 Cases From Peru
Alfredo Moscol
Applied Immunohistochemistry & Molecular Morphology, 2007
View PDFchevron_right
Treatment of T-cell non-hodgkin’lymphoma
Ronald Gartenhaus
View PDFchevron_right
Extranodal Natural Killer T-Cell Lymphoma, Nasal Type, With Minimal Osseous Involvement: Report of a Case and Literature Review
Marycarmen Flores Dueñas
Journal of oral and …, 2010
View PDFchevron_right
Conjunctival Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Arzu Sağlam
Cornea, 2015
View PDFchevron_right
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
Emily Thomas
Blood, 2010
View PDFchevron_right
Aggressive Nasal Extranodal Nk/t Cell Lymphoma: Case Report
R. Stramandinoli, Juliana L Schussel
2011
View PDFchevron_right
Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality
Michael Cheung
International Journal of Radiation Oncology Biology Physics, 2002
View PDFchevron_right
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
Albert Kwok Wai Lie
Blood, 2004
View PDFchevron_right